Marcel Van Den Brink MD, PhD

About

Dr. Marcel Van Den Brink is an internal medicine doctor based in New York, New York, board certified in Medical Oncology. He trained at the University of Leiden, Netherlands, where he earned his MD and Ph.D., and completed clinical fellowships and postdoctoral training at Duke University Medical Center, Harvard Medical School, Beth Israel Deaconess Medical Center, Dana Farber Cancer Institute, and Pittsburgh Cancer Institute.

He specializes in Oncology and treats patients with hematologic malignancies including Acute Myeloblastic Leukemia, Diffuse Large B-Cell Lymphoma, Hodgkin Lymphoma, Multiple Myeloma and Myelodysplastic Syndromes. His procedures include Bone Marrow/Stem Cell Transplant, Allogeneic Hematopoietic Stem Cell Transplantation, Chimeric Antigen Receptor (CAR) T Cell Therapy and Immunotherapy. Dr. Van Den Brink practices at Beth Israel Deaconess Medical Center and Memorial Sloan Kettering Cancer Center, and speaks English. His research focuses on strategies to improve allogeneic blood stem cell transplantation and cellular therapy, with particular attention to immune reconstitution, graft-versus-host disease and the role of the intestinal microbiome in cancer immunotherapies.